Dizocilpine (MK-801) is a potent anticonvulsant and a selective non-competitive NMDA receptor antagonist (Kd = 37.2 nM); it inhibits NMDA-induced currents and blocks NMDA-activated single-channel activity; suppresses LPS-induced microglial activation and reduces TNF-α release in BV-2 cells; attenuates methamphetamine (METH)-induced dopamine depletion and microglial activation in the striatum of mice; reduces cocaine-primed reinstatement in rats; and increases locomotor activity in mice at higher doses (0.3 and 1 mg/kg, i.p.).